"In this review we discuss all three scenarios, with a focus on the recently fast-paced discoveries describing their involvement in solid tumors. In this regard, the role of Tfh cells in TLS, in ICB therapies, and as a potential link for the development of irAEs following ICB are of particular importance."

#Immunology #Immunotherapy

https://www.cell.com/trends/cancer/fulltext/S2405-8033(22)00270-9